Symbols

BGMS

Bio Green Med·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About BGMS

Bio Green Med Solution, Inc.

A company actively exploring in the fields of biomedicine and green technology

Industry

Business Services and Business Supplies

Established Date

01/05/1996

Listing Date

03/16/2004

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.cyclacel.com

Security Type

Common stock

Office address

Level 10, Tower 11, Avenue 5, No. 8, Jalan Kerinchi, Kuala Lumpur, Malaysia 59200

Business

Introduction

Bio Green Med Solution, Inc. (formerly Cyclacel Pharmaceuticals, Inc.) is a Delaware corporation incorporated on January 5, 1996. Following the completion of the acquisition on September 12, 2025, the Company was renamed Bio Green Med Solution, Inc., from Cyclacel Pharmaceuticals, Inc., and its common stock continues to be listed on the Nasdaq Capital Market. The company focuses on the supply and trade of protective and fire safety equipment, providing various fire safety products including fire extinguishers, foam systems, fire doors, personal protective equipment and fire safety clothing, as well as "turning waste into resources" services and real estate development and construction business. With trade and distribution as its core, the company provides high-quality and certified safety solutions for commercial, industrial, medical and residential sectors. It has a solid market position in the fire safety equipment distribution industry and has a reputation in the Malaysian fire safety market for reliability and compliance with strict regulatory standards.

Company Financials

EPS

BGMS has released its 2025 Q3 earnings. EPS was reported at -1.31, versus the expected -72, beating expectations. The chart below visualizes how BGMS has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

BGMS has released its 2025 Q4 earnings report, with revenue of 666.00K, reflecting a YoY change of NaN%, and net profit of -611.00K, showing a YoY change of 79.98%. The Sankey diagram below clearly presents BGMS's revenue sources and cost distribution.